BNP Paribas Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
BNP Paribas Asset Management's LMAT Position: Q1 2026 in Review
BNP Paribas Asset Management reduced its LeMaitre Vascular (LMAT) stake by 15% in Q1 2026, selling an estimated $2.38K and leaving 144 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2094.
BNP Paribas Asset Management first reported a position in LMAT in Q2 2025 and has held it in 4 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- BNP Paribas Asset Management held 144 shares of LeMaitre Vascular worth $15.7K as of Q1 2026.
- BNP Paribas Asset Management sold 25 LeMaitre Vascular shares in Q1 2026, an estimated $2.38K.
- LeMaitre Vascular made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2094 holding.
- BNP Paribas Asset Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 4 quarters since.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.